Kinetics of free and ligand-bound atacicept in human serum
BAFF (B cell activation factor of the TNF family/B lymphocyte stimulator, BLyS) and APRIL (a proliferation-inducing ligand) are targeted by atacicept, a decoy receptor consisting of the extracellular domain of TACI (transmembrane activator and calcium-modulator and cyclophilin (CAML) interactor) fus...
Main Authors: | Mahya Eslami, Daniela Willen, Orestis Papasouliotis, Sonia Schuepbach-Mallpell, Laure Willen, Olivier Donzé, Özkan Yalkinoglu, Pascal Schneider |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1035556/full |
Similar Items
-
BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid
by: Mahya Eslami, et al.
Published: (2020-11-01) -
Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
by: Celine Kaegi, et al.
Published: (2020-03-01) -
Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
by: David A. Isenberg, et al.
Published: (2020-11-01) -
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies
by: Chee Kay Cheung, et al.
Published: (2024-02-01) -
Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma
by: Tobias Birnbaum, et al.
Published: (2013-03-01)